Media coverage
1
Media coverage
Title Biohaven Enrolls First Patient In Phase 3 Generalized Anxiety Disorder (GAD) Trial Of Troriluzole Media name/outlet BioSpace Country/Territory United States Date 20/02/19 URL https://www.biospace.com/article/releases/biohaven-enrolls-first-patient-in-phase-3-generalized-anxiety-disorder-gad-trial-of-troriluzole/ Persons Sanjay Mathew